Activity Description
In this video Selina McGee, OD and Mark Schaeffer, OD highlight the significant impact of Demodex blepharitis and MGD on vision and patient outcomes. It emphasizes early detection, comprehensive eyelid margin evaluation, and tailored management strategies to improve ocular health and quality of life.
Accreditation
Sponsored by
The Fundingsland Group, LLC is a COPE-Approved Administrator.
This activity, COPE Activity Number 129972, is accredited by COPE for continuing education for optometrists. This course is approved for .25 hours of CE.
Course # 95696-TD
Activity #: 129972
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
Release Date: 01-27-2025
Expiration Date: 01-27-2026
Grant Support Statement
This activity is supported by unrestricted educational grants from Johnson & Johnson Vision, Sight Sciences, and Tarsus Pharmaceuticals, Inc.
Faculty
Selina McGee, OD, FAAO
Mark Schaeffer, OD, FAAO